Morgan Dempsey Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-10
| Closed | -$4.06K | – | 163 |
|
|
2025
Q2 | $4.06K | Hold |
10
| – | – | ﹤0.01% | 146 |
|
|
2025
Q1 | $4.98K | Hold |
10
| – | – | ﹤0.01% | 131 |
|
|
2024
Q4 | $5.21K | Hold |
10
| – | – | ﹤0.01% | 118 |
|
|
2024
Q3 | $6.19K | Hold |
10
| – | – | ﹤0.01% | 122 |
|
|
2024
Q2 | $5.53K | Hold |
10
| – | – | ﹤0.01% | 107 |
|
|
2024
Q1 | $5.81K | Hold |
10
| – | – | ﹤0.01% | 108 |
|
|
2023
Q4 | $5.31K | Hold |
10
| – | – | ﹤0.01% | 117 |
|
|
2023
Q3 | $5.06K | Hold |
10
| – | – | ﹤0.01% | 114 |
|
|
2023
Q2 | $5.22K | Hold |
10
| – | – | ﹤0.01% | 116 |
|
|
2023
Q1 | $5.76K | Sell |
10
-10
| -50% | -$5.64K | ﹤0.01% | 114 |
|
|
2022
Q4 | $11K | Hold |
20
| – | – | ﹤0.01% | 108 |
|
|
2022
Q3 | $10K | Buy |
+20
| New | +$11.2K | ﹤0.01% | 107 |
|
|
2020
Q4 | – | Sell |
-409
| Closed | -$180K | – | 141 |
|
|
2020
Q3 | $180K | Sell |
409
-43
| -10% | -$17.8K | 0.07% | 39 |
|
|
2020
Q2 | $164K | Sell |
452
-326
| -42% | -$109K | 0.07% | 39 |
|
|
2020
Q1 | $220K | Sell |
778
-94
| -11% | -$29.6K | 0.11% | 37 |
|
|
2019
Q4 | $283K | Sell |
872
-220
| -20% | -$66.7K | 0.11% | 43 |
|
|
2019
Q3 | $318K | Hold |
1,092
| – | – | 0.12% | 89 |
|
|
2019
Q2 | $321K | Hold |
1,092
| – | – | 0.12% | 96 |
|
|
2019
Q1 | $299K | Sell |
1,092
-35
| -3% | -$8.71K | 0.12% | 99 |
|
|
2018
Q4 | $252K | Sell |
1,127
-38
| -3% | -$8.92K | 0.11% | 107 |
|
|
2018
Q3 | $284K | Hold |
1,165
| – | – | 0.11% | 107 |
|
|
2018
Q2 | $241K | Sell |
1,165
-207
| -15% | -$43.9K | 0.1% | 111 |
|
|
2018
Q1 | $283K | Sell |
1,372
-146
| -10% | -$30.6K | 0.11% | 109 |
|
|
2017
Q4 | $288K | Sell |
1,518
-20
| -1% | -$3.83K | 0.09% | 104 |
|
|
2017
Q3 | $291K | Sell |
1,538
-682
| -31% | -$124K | 0.1% | 103 |
|
|
2017
Q2 | $387K | Sell |
2,220
-62
| -3% | -$10.4K | 0.14% | 101 |
|
|
2017
Q1 | $351K | Buy |
2,282
+2
| +0.1% | +$306 | 0.13% | 100 |
|
|
2016
Q4 | $322K | Sell |
2,280
-68
| -3% | -$10K | 0.09% | 104 |
|
|
2016
Q3 | $373K | Hold |
2,348
| – | – | 0.13% | 102 |
|
|
2016
Q2 | $347K | Sell |
2,348
-60
| -2% | -$8.86K | 0.12% | 101 |
|
|
2016
Q1 | $341K | Buy |
2,408
+236
| +11% | +$31.6K | 0.12% | 99 |
|
|
2015
Q4 | $308K | Hold |
2,172
| – | – | 0.12% | 108 |
|
|
2015
Q3 | $266K | Sell |
2,172
-401
| -16% | -$52.2K | 0.09% | 110 |
|
|
2015
Q2 | $334K | Hold |
2,573
| – | – | 0.09% | 108 |
|
|
2015
Q1 | $346K | Hold |
2,573
| – | – | 0.09% | 104 |
|
|
2014
Q4 | $322K | Sell |
2,573
-600
| -19% | -$73K | 0.08% | 111 |
|
|
2014
Q3 | $386K | Buy |
3,173
+580
| +22% | +$70.5K | 0.09% | 111 |
|
|
2014
Q2 | $306K | Sell |
2,593
-1,586
| -38% | -$187K | 0.07% | 116 |
|
|
2014
Q1 | $502K | Sell |
4,179
-291
| -7% | -$34.6K | 0.12% | 104 |
|
|
2013
Q4 | $498K | Sell |
4,470
-45
| -1% | -$4.47K | 0.16% | 102 |
|
|
2013
Q3 | $416K | Sell |
4,515
-2,145
| -32% | -$194K | 0.14% | 102 |
|
|
2013
Q2 | $564K | Buy |
+6,660
| New | +$554K | 0.21% | 97 |
|
Other funds holding TMO
Morgan Dempsey Capital Management's TMO Position: Q3 2025 in Review
Morgan Dempsey Capital Management sold out of Thermo Fisher Scientific (TMO) in Q3 2025, closing a stake of 10 shares — an estimated $4.06K sold.
Morgan Dempsey Capital Management first reported a position in TMO in Q2 2013 and held it in 42 quarters. The position peaked at $564K in Q2 2013. 2,508 funds tracked by Wall St. Rank hold TMO as of Q3 2025.
- Morgan Dempsey Capital Management reported no remaining Thermo Fisher Scientific position as of Q3 2025 after selling out during the quarter.
- Morgan Dempsey Capital Management sold 10 Thermo Fisher Scientific shares in Q3 2025, an estimated $4.06K.
- Morgan Dempsey Capital Management first reported a position in Thermo Fisher Scientific in Q2 2013 and held it in 42 quarters.
- Morgan Dempsey Capital Management's Thermo Fisher Scientific position peaked at $564K in Q2 2013.
- 2,508 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2025.
Based on Morgan Dempsey Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.